{"organizations": [], "uuid": "36aca4cdd7cca9d42e0eab9e66558ce9ba89cb98", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180220.html", "section_title": "Archive News &amp; Video for Tuesday, 20 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-halozyme-reports-q4-earnings-per-s/brief-halozyme-reports-q4-earnings-per-share-0-85-idUSASB0C6II", "country": "US", "domain_rank": 408, "title": "BRIEF-Halozyme Reports Q4 Earnings Per Share $0.85", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-02-21T05:15:00.000+02:00", "replies_count": 0, "uuid": "36aca4cdd7cca9d42e0eab9e66558ce9ba89cb98"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-halozyme-reports-q4-earnings-per-s/brief-halozyme-reports-q4-earnings-per-share-0-85-idUSASB0C6II", "ord_in_thread": 0, "title": "BRIEF-Halozyme Reports Q4 Earnings Per Share $0.85", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters) - halozyme therapeutics inc", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 20 (Reuters) - Halozyme Therapeutics Inc:\n* HALOZYME REPORTS FOURTH QUARTER AND FULL-YEAR 2017 RESULTS\n* Q4 EARNINGS PER SHARE $0.85 * Q4 REVENUE $189.6 MILLION VERSUS $39 MILLION * REITERATED 2018 FINANCIAL GUIDANCE FOR NET REVENUE OF $115 MILLION TO $125 MILLION Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-21T05:15:00.000+02:00", "crawled": "2018-02-21T21:27:42.003+02:00", "highlightTitle": ""}